Pioneering Cancer Treatments through Enhanced Genomic Profiling

News (ZH) - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

News (ZH) - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning

News (ZH) - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes 

LGC mid-year Update: 1 April – 30 September 2023

News (ZH) - LGC announces half year trading results

LGC acquires PolyDesign

News (ZH) - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.   

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

News (ZH) - National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.  

LGC acquires Virusys Corporation.

News (ZH) - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

LGC Group appoints David King as Non-Executive Director and Chairman

News (ZH) - LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.

Review of methods and challenges associated with detection of Precision Bred Products

News (ZH) - The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.

LGC acquires Kova International, Inc., including Biochemical Diagnostics, Inc., strengthening its portfolio of Quality Measurement Tools

News (ZH) - Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories